40 C.F.R. § 721.11008

Current through October 31, 2024
Section 721.11008 - Hydroxy functional triglyceride polymer with glycerol mono-ester and 1,1'-methylenebis[4-isocyanatobenzene] (generic)
(a)Chemical substances and significant new uses subject to reporting.
(1) The chemical substance identified generically as hydroxy functional triglyceride polymer with glycerol mono-ester and 1,1'-methylenebis[4-isocyanatobenzene] (PMN P-16-330) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(2) The significant new uses are:
(i)Protection in the workplace. Requirements as specified in § 721.63(a)(1), (a)(2)(i), (iii), and (iv), (a)(3), and (b) (concentration set at 0.1 percent)
(ii)Hazard communication. Requirements as specified in § 721.72(a) through (e) (concentration set at 1.0 percent), (f), (g)(1)(i) and (ii), (g)(2)(i), (ii), (iii), and (v), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used.
(iii)Industrial, commercial, and consumer activities. Requirements as specified in § 721.80 . It is a significant new use to manufacture the PMN substance to contain a residual of isocyanate greater than 0.1 weight percent. It is a significant new use to sell the substance for "consumer use" or for "commercial uses" (as the term is defined at § 721.3 ) when the "saleable goods or service" could introduce the substance into a "consumer" setting (as that term is defined in § 721.3 ).
(b)Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph (b).
(1)Recordkeeping. Recordkeeping requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance.
(2)Limitations or revocation of certain notification requirements. The provisions of § 721.185 apply to this section.

40 C.F.R. §721.11008

82 FR 48651 , Oct. 19, 2017
82 FR 48651 , 12/18/2017